Want to see HSIC full AI Analyst Report?
HSIC Stock Chart & Stats
$78.83
-$1.28(-1.78%)
At close: 4:00 PM EST
$78.83
-$1.28(-1.78%)
Day’s Range― - ―
52-Week Range$61.95 - $89.34
Previous CloseN/A
Volume226.89K
Average Volume (3M)1.28M
Market Cap
$9.66B
Enterprise Value$13.54K
Total Cash (Recent Filing)$138.00M
Total Debt (Recent Filing)$3.75B
Price to Earnings (P/E)25.3
Beta0.31
Next Earnings
Aug 04, 2026EPS Estimate
1.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.34
Shares Outstanding113,916,756
10 Day Avg. Volume1,389,561
30 Day Avg. Volume1,278,409
Financial Highlights & Ratios
PEG Ratio3.23
Price to Book (P/B)2.83
Price to Sales (P/S)0.70
P/FCF Ratio16.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$86.25Price Target Upside9.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)5.35
Revenue Forecast (FY)$13.75B
Bulls Say, Bears Say
Bulls Say
Diversified Recurring Revenue And Distribution ScaleHenry Schein’s core model—high-frequency consumables plus equipment and services—creates predictable reorder streams and customer stickiness. Its distribution scale and supplier relationships reduce unit costs and support durable revenue base, cushioning cyclicality and enabling cross-sell of higher‑margin services over time.
Growing Cloud/software & Value-added Services MixThe shift toward cloud subscriptions, practice software and value-added services increases recurring, higher-margin revenue. As operating income mix tilts toward software/services, earnings become less dependent on low-margin product distribution, improving long-term margin resilience and predictability.
Explicit Multi-year Value-creation And Cost PlanManagement’s quantified cost and gross-profit program (procurement, outsourcing, pricing) provides a clear roadmap to boost operating income. If executed, these structural actions can sustainably lift margins and cash flow over multiple years, reducing execution risk tied to cyclical product sales.
Bears Say
Materially Higher LeverageThe sizable increase in debt materially reduces financial flexibility and raises interest and refinancing risk. Higher leverage means returns are now achieved with more financial risk, constraining capital allocation and leaving less cushion if cash generation weakens or execution on cost savings slips.
Sustained Margin Compression Vs. Prior YearsStructural margin pressure—driven by mix shifts toward lower‑margin implant products and pricing competition in digital equipment—reduces profitability headroom. Even with improving non‑GAAP margins, GAAP margins and net income remain lower, limiting long‑term earnings power absent sustained mix improvement.
Weakened Free Cash Flow And Seasonal OCF VariabilityDeclining FCF and volatile, seasonally negative quarterly OCF reduce capacity to deleverage, fund buybacks, or invest in growth. This weakens the company’s ability to absorb shocks and increases reliance on executing cost-savings to meet targets and service elevated debt levels over the medium term.
Henry Schein News
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $61.95 and its highest was $89.34 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.66B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 04, 2026 which is in 11 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.218 by $0.102.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.24.
How many shares outstanding does Henry Schein have?
Henry Schein has 113,916,756 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.32 in its last earnings report, beating expectations of $1.218. Following the earnings report the stock price went up 3.263%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$86.25 (9.41% Upside)
$86.25 (9.41% Upside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 170.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $691.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
HSIC Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations
HSIC Stock 12 Month Forecast
Average Price Target
$86.25
▲(9.41% Upside)
Technical Analysis
Ownership Overview
1.33% Insiders
29.09% Mutual Funds
0.37% Other Institutional Investors
45.67% Public Companies and
Individual Investors